A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first line combination versus sequential gemcitabine and docetaxel: Interim study results

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7095 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7095-7095 ◽

Author(s):

A. Mueller ◽

N. Thatcher ◽

C. Kortsik ◽

G. Koschel ◽

W. Spengler ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Randomized Study ◽

Small Cell Lung ◽

Download Full-text

A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first line combination versus sequential gemcitabine and docetaxel: Interim study results

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7095 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7095-7095

Author(s):

A. Mueller ◽

N. Thatcher ◽

C. Kortsik ◽

G. Koschel ◽

W. Spengler ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Randomized Study ◽

Small Cell Lung ◽

Download Full-text

A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer

Annals of Oncology ◽

10.1093/annonc/mdu384 ◽

2014 ◽

Vol 25 (11) ◽

pp. 2156-2162 ◽

Author(s):

S. Novello ◽

B. Besse ◽

E. Felip ◽

F. Barlesi ◽

J. Mazieres ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Randomized Study ◽

Small Cell Lung ◽

First Line Therapy ◽

Download Full-text

1664TiP A phase II randomized study of BMS-986012, an anti-fucosyl-GM1 monoclonal antibody, plus carboplatin, etoposide, and nivolumab (NIVO) as first-line (1L) therapy in patients with extensive-stage small cell lung cancer (ES-SCLC)

Annals of Oncology ◽

10.1016/j.annonc.2021.08.248 ◽

2021 ◽

Vol 32 ◽

pp. S1170

Author(s):

Q. Chu ◽

K. Parikh ◽

L. Paz-Ares ◽

A. Navarro ◽

B. Markman ◽

...

Keyword(s):

Lung Cancer ◽

Monoclonal Antibody ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Randomized Study ◽

Small Cell Lung ◽

Extensive Stage

Download Full-text

A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first line combination versus sequential gemcitabine (G) and docetaxel (D): Update on quality of life (QoL), toxicity, and costs

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7057 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7057-7057 ◽

Author(s):

C. Manegold ◽

N. Thatcher ◽

C. Kortsik ◽

G. Koschel ◽

W. Spengler ◽

...

Keyword(s):

Quality Of Life ◽

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Randomized Study ◽

Small Cell Lung ◽

Download Full-text

Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer

Lung Cancer ◽

10.1016/s0169-5002(02)00387-2 ◽

2003 ◽

Vol 39 (1) ◽

pp. 77-84 ◽

Author(s):

J.M Vieitez ◽

M Valladares ◽

M Gracia ◽

M Gonzalez-Barón ◽

G Martı́n ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

A Phase II Randomized Study of Paclitaxel Plus Carboplatin or Cisplatin against Chemo-Naive Inoperable Non-small Cell Lung Cancer in the Elderly

Journal of Thoracic Oncology ◽

10.1097/01243894-200602000-00007 ◽

2006 ◽

Vol 1 (2) ◽

pp. 141-145 ◽

Author(s):

Yuh-Min Chen ◽

Reury-Perng Perng ◽

Chun-Ming Tsai ◽

Jacqueline Whang-Peng

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Randomized Study ◽

The Elderly ◽

Small Cell Lung

Download Full-text

Randomized, Multi-center Phase II Trial of Docetaxel Plus Cisplatin Versus Etoposide Plus Cisplatin as the First-line Therapy for Patients with Advanced Non-Small Cell Lung Cancer

Cancer Research and Treatment ◽

10.4143/crt.2005.37.6.332 ◽

2005 ◽

Vol 37 (6) ◽

pp. 332

Author(s):

Nam-Su Lee ◽

Hee-Sook Park ◽

Jong-Ho Won ◽

Dae-Sik Hong ◽

Su-Taek Uh ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

First Line Therapy ◽

Download Full-text

Randomised Phase II Study of Axitinib or Bevacizumab Combined with Paclitaxel/Carboplatin (PAC/CARB) as First-Line Therapy for Patients (PTS) with Advanced Non–Small Cell Lung Cancer (NSCLC)

Annals of Oncology ◽

10.1016/s0923-7534(20)33840-0 ◽

2012 ◽

Vol 23 ◽

pp. ix408

Author(s):

C. Twelves ◽

E. Chmielowska ◽

L. Havel ◽

S. Popat ◽

A. Swieboda-Sadlej ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

First Line Therapy ◽

Download Full-text

1325 A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients (75-years-old) with advanced non-squamous, non-small cell lung cancer

European Journal of Cancer ◽

10.1016/s0959-8049(16)30568-8 ◽

2015 ◽

Vol 51 ◽

pp. S196

Author(s):

M. Tamiya ◽

A. Tamiya ◽

H. Kaneda ◽

K. Nakagawa ◽

K. Goto ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Line Chemotherapy

Download Full-text

Phase-II trial of taxotere (TXT) and Navelbine (N) as first-line therapy in patients (PTS) with advanced non-small cell lung cancer (ANSCLC)

Lung Cancer ◽

10.1016/s0169-5002(99)90743-2 ◽

1999 ◽

Vol 25 ◽

pp. S19-S20

Author(s):

M. O'Rourke ◽

D. Garfield ◽

P. Ellis

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

First Line Therapy ◽

Download Full-text